From monoclonal antibodies to peptides and molecular recognition units: An overview

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Various antigen-specific monoclonal antibodies (Mabs) are now being used clinically. Applications include in vitro testing (radioimmunoassay) and in vivo imaging (radioimmunoscintigraphy) for the early detection and staging of disease. Mabs can also be used as vehicles for delivering therapy (radioimmunotherapy) or to assess effects of therapeutic interventions. This review delineates those components making up antibody structure and discusses their functional significance. The method for radiolabeling immunoconjugates without altering their immunoreactivity or biological properties is dependent on an understanding of the structural units of the antibody and the labeling technique used. With the advent of genetic engineering, it has become feasible to design antibodies to circumvent certain adverse features or enhance a certain property. A review of the various 'designer' antibodies and their relative advantages in the clinical setting is presented.

Original languageEnglish
Pages (from-to)533-536
Number of pages4
JournalJournal of Nuclear Medicine
Volume34
Issue number3 SUPPL.
StatePublished - Jan 1 1993

Fingerprint

Monoclonal Antibodies
Peptides
Antibodies
Radioimmunodetection
Immunoconjugates
Radioimmunotherapy
Genetic Engineering
Therapeutic Uses
Radioimmunoassay
Early Diagnosis
Antigens
Therapeutics

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

From monoclonal antibodies to peptides and molecular recognition units : An overview. / Serafini, Aldo N.

In: Journal of Nuclear Medicine, Vol. 34, No. 3 SUPPL., 01.01.1993, p. 533-536.

Research output: Contribution to journalArticle

@article{ba99bb9954354c359089d7534585543c,
title = "From monoclonal antibodies to peptides and molecular recognition units: An overview",
abstract = "Various antigen-specific monoclonal antibodies (Mabs) are now being used clinically. Applications include in vitro testing (radioimmunoassay) and in vivo imaging (radioimmunoscintigraphy) for the early detection and staging of disease. Mabs can also be used as vehicles for delivering therapy (radioimmunotherapy) or to assess effects of therapeutic interventions. This review delineates those components making up antibody structure and discusses their functional significance. The method for radiolabeling immunoconjugates without altering their immunoreactivity or biological properties is dependent on an understanding of the structural units of the antibody and the labeling technique used. With the advent of genetic engineering, it has become feasible to design antibodies to circumvent certain adverse features or enhance a certain property. A review of the various 'designer' antibodies and their relative advantages in the clinical setting is presented.",
author = "Serafini, {Aldo N}",
year = "1993",
month = "1",
day = "1",
language = "English",
volume = "34",
pages = "533--536",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "3 SUPPL.",

}

TY - JOUR

T1 - From monoclonal antibodies to peptides and molecular recognition units

T2 - An overview

AU - Serafini, Aldo N

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Various antigen-specific monoclonal antibodies (Mabs) are now being used clinically. Applications include in vitro testing (radioimmunoassay) and in vivo imaging (radioimmunoscintigraphy) for the early detection and staging of disease. Mabs can also be used as vehicles for delivering therapy (radioimmunotherapy) or to assess effects of therapeutic interventions. This review delineates those components making up antibody structure and discusses their functional significance. The method for radiolabeling immunoconjugates without altering their immunoreactivity or biological properties is dependent on an understanding of the structural units of the antibody and the labeling technique used. With the advent of genetic engineering, it has become feasible to design antibodies to circumvent certain adverse features or enhance a certain property. A review of the various 'designer' antibodies and their relative advantages in the clinical setting is presented.

AB - Various antigen-specific monoclonal antibodies (Mabs) are now being used clinically. Applications include in vitro testing (radioimmunoassay) and in vivo imaging (radioimmunoscintigraphy) for the early detection and staging of disease. Mabs can also be used as vehicles for delivering therapy (radioimmunotherapy) or to assess effects of therapeutic interventions. This review delineates those components making up antibody structure and discusses their functional significance. The method for radiolabeling immunoconjugates without altering their immunoreactivity or biological properties is dependent on an understanding of the structural units of the antibody and the labeling technique used. With the advent of genetic engineering, it has become feasible to design antibodies to circumvent certain adverse features or enhance a certain property. A review of the various 'designer' antibodies and their relative advantages in the clinical setting is presented.

UR - http://www.scopus.com/inward/record.url?scp=0027536478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027536478&partnerID=8YFLogxK

M3 - Article

C2 - 8441052

AN - SCOPUS:0027536478

VL - 34

SP - 533

EP - 536

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 3 SUPPL.

ER -